ETC
ANIK icon

Exchange Traded Concepts’s Anika Therapeutics ANIK Stock Holding History

Exchange Traded Concepts’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,074
Closed -$448K – 1156
2022
Q2 		$448K Buy
20,074
+460
+2% +$10.3K 0.01% 562
2022
Q1 		$493K Buy
+19,614
New +$598K 0.01% 671

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Exchange Traded Concepts's ANIK Position: Q3 2022 in Review

Exchange Traded Concepts sold out of Anika Therapeutics (ANIK) in Q3 2022, closing a stake of 20,074 shares — an estimated $448K sold.

Exchange Traded Concepts first reported a position in ANIK in Q1 2022 and held it in 2 quarters. The position peaked at $493K in Q1 2022. 121 funds tracked by Wall St. Rank hold ANIK as of Q3 2022.

  • Exchange Traded Concepts reported no remaining Anika Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Exchange Traded Concepts sold 20,074 Anika Therapeutics shares in Q3 2022, an estimated $448K.
  • Exchange Traded Concepts first reported a position in Anika Therapeutics in Q1 2022 and held it in 2 quarters.
  • Exchange Traded Concepts's Anika Therapeutics position peaked at $493K in Q1 2022.
  • 121 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2022.

Based on Exchange Traded Concepts's 13F filing for Q3 2022, filed 7 Oct 2022.